Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Clinical Immunology (Orlando, Fla.)
|
April 5, 2001
Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion
K D Miller, K Spooner, B R Herpin, et al.
Nature Medicine
|
May 1, 1997
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
M Connors, J A Kovacs, S Krevat, et al.
The Journal of Infectious Diseases
|
July 1, 1996
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1
R E Walker, K M Spooner, G Kelly, et al.
The Journal of Infectious Diseases
|
April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial
J A Kovacs, C Bechtel, R T Davey, et al.
The Journal of Infectious Diseases
|
September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression
J A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection
M A Polis, S C Piscitelli, S Vogel, et al.
AIDS (London, England)
|
November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient
J M Orenstein, M Feinberg, C Yoder, et al.
The Journal of Infectious Diseases
|
March 9, 1999
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection
R T Davey, D G Chaitt, J M Albert, et al.
European Journal of Immunology
|
July 24, 2001
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy
J A Kovacs, S Vogel, J A Metcalf, et al.
Nature Medicine
|
July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults
R E Walker, C S Carter, L Muul, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Clinical Immunology (Orlando, Fla.)
|
April 5, 2001
Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion
K D Miller, K Spooner, B R Herpin, et al.
Nature Medicine
|
May 1, 1997
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
M Connors, J A Kovacs, S Krevat, et al.
The Journal of Infectious Diseases
|
July 1, 1996
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1
R E Walker, K M Spooner, G Kelly, et al.
The Journal of Infectious Diseases
|
April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial
J A Kovacs, C Bechtel, R T Davey, et al.
The Journal of Infectious Diseases
|
September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression
J A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection
M A Polis, S C Piscitelli, S Vogel, et al.
AIDS (London, England)
|
November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient
J M Orenstein, M Feinberg, C Yoder, et al.
The Journal of Infectious Diseases
|
March 9, 1999
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection
R T Davey, D G Chaitt, J M Albert, et al.
European Journal of Immunology
|
July 24, 2001
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy
J A Kovacs, S Vogel, J A Metcalf, et al.
Nature Medicine
|
July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults
R E Walker, C S Carter, L Muul, et al.
Page
of 9